Welcome to our dedicated page for American Well SEC filings (Ticker: AMWL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Well Corporation filings document the company’s SaaS-based technology-enabled healthcare platform, operating results, customer agreements, governance, and equity-compensation structure. Its Form 8-K filings include earnings reports for quarterly and annual periods, material definitive agreements, board changes, and related exhibit disclosures.
AMWL filings also describe commercial arrangements tied to digital care delivery, including the company’s operation of a white-labeled platform under the LiveHealth Online brand for Elevance Health and related clinical-provider access through Online Care Group. Proxy materials cover director elections, executive compensation, equity awards, stockholder voting matters, and board governance for the public company.
American Well Corp director Stephen J. Schlegel reported an open-market sale of 9,750 shares of Class A Common Stock at $8.764 per share. The transaction occurred on June 11, 2026 and was executed under a Rule 10b5-1 trading plan.
According to the filing, the plan was adopted on February 17, 2026 and the sale was made to cover tax liabilities from the vesting and settlement of restricted stock units on June 11, 2026. After this sale, Schlegel directly holds 54,553 shares of American Well Corp Class A Common Stock.
American Well Corp’s Chief Financial Officer Mark Hirschhorn reported an automatic sale of 10,761 shares of Class A Common Stock on June 1, 2026 at $9.74 per share. According to the disclosure, this "sell to cover" transaction was executed solely to pay taxes arising from the vesting and settlement of restricted stock units on that date and did not represent a discretionary trade. Following the sale, Hirschhorn directly holds 243,238 shares.
American Well Corp President, International Phyllis Gotlib reported an automatic share sale primarily to cover taxes on vested equity. On June 1, 2026, she sold 3,573 shares of Class A Common Stock at $9.74 per share in an open-market sale designated as a “sell to cover” transaction. After this sale, she held 159,431 shares directly and 114,920 shares indirectly through her husband. The footnote explains that the transaction was executed automatically to satisfy tax liabilities from restricted stock unit vesting and did not represent a discretionary trade.
American Well Corp Chief Accounting Officer Paul Francis McNeice reported an open-market sale of 112 shares of Class A Common Stock at $9.74 per share on June 1, 2026. According to the footnote, this automatic “sell to cover” trade was executed solely to pay taxes arising from the vesting and settlement of restricted stock units on that date and did not represent a discretionary trade. Following the sale, McNeice directly holds 10,504 shares of Class A Common Stock.
American Well Corporation reports a Form 144 notice relating to 15,890 shares of Class A Common Stock associated with the vesting of a restricted stock unit grant on 06/01/2026. The filing also records that 10,796 shares were sold on 03/02/2026 by Mark Hirschhorn for $56,603.43.
American Well Corporation affiliate submitted a Form 144 notice reporting proposed and recent transactions in Class A Common Stock. The notice lists 6,786 shares tied to the vesting of a Restricted Stock Unit grant dated 06/01/2026. It also records prior dispositions of 3,706 shares on 04/01/2026 and 3,573 shares on 03/02/2026 by Phyllis Gotlib.
American Well Corp: Senvest Management, LLC and Richard Mashaal reported beneficial ownership of 1,136,558 shares of Class A Common Stock, representing 7.6% of the class. The percentage is calculated using 14,904,513 shares outstanding as of January 30, 2026, per the company's Form 10-K.
Those shares are held in accounts for Senvest Master Fund, LP and Senvest Technology Partners Master Fund, LP; Senvest Management, LLC and Mr. Mashaal report shared voting and shared dispositive power over the reported shares.
American Well Corporation reports that co-founder Dr. Roy Schoenberg has resigned from its Board of Directors, effective May 6, 2026. The company explains that he is leaving in connection with a new employment opportunity.
His resignation is described as not resulting from any disagreement with American Well on operations, policies, or procedures. The company highlights his nearly twenty years of leadership, including service as Executive Vice Chairman of the Board, and credits him with a lasting impact on its growth and evolution.
American Well Corp director and co-CEO Ido Schoenberg reported a small open-market share purchase. On May 7, 2026, he bought 670 shares of Class A Common Stock at $7.37 per share in an open-market transaction, increasing his direct holdings to 114,920 shares. The filing also shows indirect ownership of 163,004 shares held by his wife.